{
    "title": "Amgen's Humira copy succeeds in skin disease trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2785311/Amgens-Humira-copy-succeeds-skin-disease-trial.html",
    "date": "2014-10-08",
    "keywords": [
        "trial",
        "drug",
        "psoriasis",
        "disease",
        "october",
        "latestage",
        "development",
        "sector",
        "copy",
        "gmt",
        "email",
        "oct",
        "inc",
        "version",
        "blockbuster",
        "humira",
        "safety",
        "ability",
        "response",
        "type",
        "dysfunction",
        "immune",
        "system",
        "patcheshumira",
        "rheumatoid",
        "arthritis",
        "injection",
        "number",
        "plaque",
        "december",
        "manufacturing",
        "expertise",
        "success",
        "competition",
        "deutsche",
        "bank",
        "note",
        "value",
        "business",
        "share",
        "percent",
        "probabilityamgen",
        "portfolio",
        "goal",
        "improvement",
        "area",
        "severity",
        "index",
        "measure",
        "redness",
        "thickness",
        "scaliness",
        "week",
        "amgen",
        "saidthis",
        "companys",
        "drugdrug",
        "market",
        "biotech",
        "study",
        "unit",
        "pfizer",
        "afternoon",
        "trading",
        "nasdaq",
        "amrutha",
        "penumudi",
        "bangalore"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}